CA1200774A - Liens d'expression - Google Patents

Liens d'expression

Info

Publication number: CA1200774A
Authority: CA; Canada
Prior art keywords: sequence; linker; specific; amino acid; protein
Prior art date: 1980-02-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000452925A

Other languages

English (en)

Inventor

William J. Rutter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California San Diego UCSD

Original Assignee

University of California San Diego UCSD

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-02-29

Filing date

1984-04-26

Publication date

1986-02-18

1981-02-25 Priority claimed from CA000371674A external-priority patent/CA1200773A/fr

1984-04-26 Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD

1984-04-26 Priority to CA000452925A priority Critical patent/CA1200774A/fr

1986-02-18 Application granted granted Critical

1986-02-18 Publication of CA1200774A publication Critical patent/CA1200774A/fr

Status Expired legal-status Critical Current

Links

238000000746 purification Methods 0.000 claims abstract description 52
239000000463 material Substances 0.000 claims abstract description 9
239000007790 solid phase Substances 0.000 claims abstract description 8
238000003776 cleavage reaction Methods 0.000 claims description 126
230000007017 scission Effects 0.000 claims description 125
230000027455 binding Effects 0.000 claims description 53
210000003705 ribosome Anatomy 0.000 claims description 43
150000001413 amino acids Chemical group 0.000 claims description 35
229940024606 amino acid Drugs 0.000 claims description 29
239000000126 substance Substances 0.000 claims description 18
230000002255 enzymatic effect Effects 0.000 claims description 17
108090000765 processed proteins & peptides Proteins 0.000 claims description 17
108091008146 restriction endonucleases Proteins 0.000 claims description 16
108020004705 Codon Proteins 0.000 claims description 13
108020005038 Terminator Codon Proteins 0.000 claims description 7
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 6
108020004465 16S ribosomal RNA Proteins 0.000 claims description 5
230000002209 hydrophobic effect Effects 0.000 claims description 5
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
229960000310 isoleucine Drugs 0.000 claims description 2
239000004474 valine Substances 0.000 claims description 2
230000002163 immunogen Effects 0.000 claims 1
108020001507 fusion proteins Proteins 0.000 abstract description 70
102000037865 fusion proteins Human genes 0.000 abstract description 69
125000003275 alpha amino acid group Chemical group 0.000 abstract description 45
230000004927 fusion Effects 0.000 abstract description 10
108090000623 proteins and genes Proteins 0.000 description 186
102000004169 proteins and genes Human genes 0.000 description 134
235000018102 proteins Nutrition 0.000 description 132
108020004414 DNA Proteins 0.000 description 48
102000053602 DNA Human genes 0.000 description 48
102000004190 Enzymes Human genes 0.000 description 44
108090000790 Enzymes Proteins 0.000 description 44
210000004027 cell Anatomy 0.000 description 44
229940088598 enzyme Drugs 0.000 description 44
238000012546 transfer Methods 0.000 description 34
239000013598 vector Substances 0.000 description 33
108091028043 Nucleic acid sequence Proteins 0.000 description 29
238000000034 method Methods 0.000 description 29
239000002773 nucleotide Substances 0.000 description 28
125000003729 nucleotide group Chemical group 0.000 description 27
235000001014 amino acid Nutrition 0.000 description 24
108010076181 Proinsulin Proteins 0.000 description 21
239000000047 product Substances 0.000 description 21
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 20
230000014616 translation Effects 0.000 description 20
238000003780 insertion Methods 0.000 description 19
230000037431 insertion Effects 0.000 description 19
238000013519 translation Methods 0.000 description 19
239000013612 plasmid Substances 0.000 description 18
108010013369 Enteropeptidase Proteins 0.000 description 17
102100029727 Enteropeptidase Human genes 0.000 description 17
230000007062 hydrolysis Effects 0.000 description 16
238000006460 hydrolysis reaction Methods 0.000 description 16
125000000539 amino acid group Chemical group 0.000 description 13
244000005700 microbiome Species 0.000 description 13
108090000631 Trypsin Proteins 0.000 description 11
102000004142 Trypsin Human genes 0.000 description 11
239000012588 trypsin Substances 0.000 description 11
229960001322 trypsin Drugs 0.000 description 11
239000004475 Arginine Substances 0.000 description 10
108010076504 Protein Sorting Signals Proteins 0.000 description 10
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 10
230000008901 benefit Effects 0.000 description 10
239000002131 composite material Substances 0.000 description 10
230000000977 initiatory effect Effects 0.000 description 10
238000013518 transcription Methods 0.000 description 10
230000035897 transcription Effects 0.000 description 10
238000003786 synthesis reaction Methods 0.000 description 9
108091081024 Start codon Proteins 0.000 description 8
150000002500 ions Chemical class 0.000 description 8
108020004999 messenger RNA Proteins 0.000 description 8
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 7
210000004899 c-terminal region Anatomy 0.000 description 7
239000012634 fragment Substances 0.000 description 7
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 7
102000004196 processed proteins & peptides Human genes 0.000 description 7
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
230000002068 genetic effect Effects 0.000 description 6
235000006109 methionine Nutrition 0.000 description 6
238000012986 modification Methods 0.000 description 6
230000004048 modification Effects 0.000 description 6
125000006850 spacer group Chemical group 0.000 description 6
108091026890 Coding region Proteins 0.000 description 5
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 5
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
RWQNBRDOKXIBIV-UHFFFAOYSA-N Thymine Natural products CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 5
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
230000000295 complement effect Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
239000003999 initiator Substances 0.000 description 5
238000005304 joining Methods 0.000 description 5
229930182817 methionine Natural products 0.000 description 5
239000012071 phase Substances 0.000 description 5
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
108010042407 Endonucleases Proteins 0.000 description 4
241000588724 Escherichia coli Species 0.000 description 4
108060005987 Kallikrein Proteins 0.000 description 4
102000001399 Kallikrein Human genes 0.000 description 4
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
108090000526 Papain Proteins 0.000 description 4
239000004365 Protease Substances 0.000 description 4
108020004511 Recombinant DNA Proteins 0.000 description 4
108090000190 Thrombin Proteins 0.000 description 4
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 4
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 4
239000013613 expression plasmid Substances 0.000 description 4
238000010348 incorporation Methods 0.000 description 4
239000008101 lactose Substances 0.000 description 4
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 4
229940055729 papain Drugs 0.000 description 4
235000019834 papain Nutrition 0.000 description 4
229920001184 polypeptide Polymers 0.000 description 4
230000008569 process Effects 0.000 description 4
229960004072 thrombin Drugs 0.000 description 4
108010087967 type I signal peptidase Proteins 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
101800004538 Bradykinin Proteins 0.000 description 3
102400000967 Bradykinin Human genes 0.000 description 3
108090000746 Chymosin Proteins 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 3
102100031780 Endonuclease Human genes 0.000 description 3
241000206602 Eukaryota Species 0.000 description 3
UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Natural products O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 3
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Natural products O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
229940080701 chymosin Drugs 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
239000000758 substrate Substances 0.000 description 3
229940113082 thymine Drugs 0.000 description 3
108020004463 18S ribosomal RNA Proteins 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
102000004400 Aminopeptidases Human genes 0.000 description 2
108090000915 Aminopeptidases Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
239000003463 adsorbent Substances 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
230000029142 excretion Effects 0.000 description 2
239000012467 final product Substances 0.000 description 2
230000003301 hydrolyzing effect Effects 0.000 description 2
230000000984 immunochemical effect Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000002609 medium Substances 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
239000002674 ointment Substances 0.000 description 2
229940111202 pepsin Drugs 0.000 description 2
238000001243 protein synthesis Methods 0.000 description 2
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
230000002194 synthesizing effect Effects 0.000 description 2
230000009466 transformation Effects 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
229960005356 urokinase Drugs 0.000 description 2
108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
230000007018 DNA scission Effects 0.000 description 1
229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 1
125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
101710192606 Latent membrane protein 2 Proteins 0.000 description 1
108091036060 Linker DNA Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
USPFMEKVPDBMCG-LBPRGKRZSA-N N-benzyloxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 USPFMEKVPDBMCG-LBPRGKRZSA-N 0.000 description 1
NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical class O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108010067372 Pancreatic elastase Proteins 0.000 description 1
102000016387 Pancreatic elastase Human genes 0.000 description 1
OZILORBBPKKGRI-RYUDHWBXSA-N Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 OZILORBBPKKGRI-RYUDHWBXSA-N 0.000 description 1
PYOHODCEOHCZBM-RYUDHWBXSA-N Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 PYOHODCEOHCZBM-RYUDHWBXSA-N 0.000 description 1
102100038124 Plasminogen Human genes 0.000 description 1
108010051456 Plasminogen Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
101710109576 Terminal protein Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
241000700605 Viruses Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
CTCBPRXHVPZNHB-VQFZJOCSSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O CTCBPRXHVPZNHB-VQFZJOCSSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
238000005349 anion exchange Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000012010 growth Effects 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
-1 i.e. Proteins 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
230000010039 intracellular degradation Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
150000002597 lactoses Chemical class 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000006166 lysate Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
108090000021 oryzin Proteins 0.000 description 1
108010018625 phenylalanylarginine Proteins 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001817 pituitary effect Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
230000037425 regulation of transcription Effects 0.000 description 1
230000009712 regulation of translation Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
238000009966 trimming Methods 0.000 description 1
108010060175 trypsinogen activation peptide Proteins 0.000 description 1
230000007306 turnover Effects 0.000 description 1
101150041325 vopp1 gene Proteins 0.000 description 1
239000012130 whole-cell lysate Substances 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

CA000452925A 1980-02-29 1984-04-26 Liens d'expression Expired CA1200774A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000452925A CA1200774A (fr)	1980-02-29	1984-04-26	Liens d'expression

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US12587880A	1980-02-29	1980-02-29
US125,878		1980-02-29
CA000371674A CA1200773A (fr)	1980-02-29	1981-02-25	Liens d'expression
CA000452925A CA1200774A (fr)	1980-02-29	1984-04-26	Liens d'expression

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000371674A Division CA1200773A (fr)	1980-02-29	1981-02-25	Liens d'expression

Publications (1)

Publication Number	Publication Date
CA1200774A true CA1200774A (fr)	1986-02-18

Family

ID=25669263

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CA000452925A Expired CA1200774A (fr)	1980-02-29	1984-04-26	Liens d'expression
CA000452926A Expired CA1200775A (fr)	1980-02-29	1984-04-26	Liens d'expression
CA000452927A Expired CA1201075A (fr)	1980-02-29	1984-04-26	Liens d'expression

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CA000452926A Expired CA1200775A (fr)	1980-02-29	1984-04-26	Liens d'expression
CA000452927A Expired CA1201075A (fr)	1980-02-29	1984-04-26	Liens d'expression

Country Status (1)

Country	Link
CA (3)	CA1200774A (fr)

1984
- 1984-04-26 CA CA000452925A patent/CA1200774A/fr not_active Expired
- 1984-04-26 CA CA000452926A patent/CA1200775A/fr not_active Expired
- 1984-04-26 CA CA000452927A patent/CA1201075A/fr not_active Expired

Also Published As

Publication number	Publication date
CA1201075A (fr)	1986-02-25
CA1200775A (fr)	1986-02-18

Publication	Publication Date	Title
US4769326A (en)	1988-09-06	Expression linkers
CA1200773A (fr)	1986-02-18	Liens d'expression
US4431740A (en)	1984-02-14	DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
US5212058A (en)	1993-05-18	Nucleic acid encoding ubiquitin-specific proteases
EP0531404B1 (fr)	1995-04-19	Protease specifique de l'ubiquitine
JP2686090B2 (ja)	1997-12-08	新規融合蛋白質およびその精製方法
JP2694840B2 (ja)	1997-12-24	ポリペプチドを微生物により発現させる方法
US4601980A (en)	1986-07-22	Microbial expression of a gene for human growth hormone
JPH0669369B2 (ja)	1994-09-07	安定化された組換えｄｎａ宿主細胞
JPH07106157B2 (ja)	1995-11-15	ヒルジン誘導体、その取得法、組換えｄｎａ及び組換えベクター
KR100858833B1 (ko)	2008-09-17	효모에 의해 분비되는 재조합 단백질의 제조를 위한,ｎ-말단 부분이 히루딘 유도체인 융합 단백질의 용도
US4650761A (en)	1987-03-17	Method for stabilizing and selecting recombinant DNA containing host cell
CA1180289A (fr)	1985-01-02	Genes de la proinsuline et de la pre-proinsuline humaines
US4828988A (en)	1989-05-09	Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine
US5858724A (en)	1999-01-12	Recombinant rabbit tissue factor
EP0300459A2 (fr)	1989-01-25	Inhibitor de trypsine sécrété par le pancréas humain
CA1200774A (fr)	1986-02-18	Liens d'expression
JP2769541B2 (ja)	1998-06-25	平衡型構成誘導性転写系
KR100714116B1 (ko)	2007-05-07	췌장의 프로카복시펩티다제 ｂ를 사용한 인슐린의 제조
JP2525413B2 (ja)	1996-08-21	Ｌ−フェニルアラニン・アンモニアリア−ゼ発現用組換え体プラスミド及び該プラスミドを有する形質転換株
JP2538200B2 (ja)	1996-09-25	ポリペプチド分泌発現ベクタ―及び形質転換微生物
CA1302321C (fr)	1992-06-02	Preparation de polypeptides
JPS6137099A (ja)	1986-02-21	蛋白質の製造法
JPH0673455B2 (ja)	1994-09-21	プロキモシンの製造方法
JPS63133986A (ja)	1988-06-06	分泌シグナルペプチドをコ−ドするｄｎａ配列

Legal Events

Date	Code	Title	Description
2003-02-18	MKEX	Expiry